Canadian Pharmacy Finds Older Women More Susceptible To Breast Cancer

Breast cancer has affected over 23,000 Canadian women in the year 2011 claiming more than 5,000 lives. The number of women diagnosed with the disease continues to increase day by day. Our generic Canadian pharmacy believes approximately 64 women in Canada are diagnosed with cancer every day. According to a recent study funded by the Dutch Cancer Society, risk of fatality due to hormone receptor-positive breast cancer is directly related to age of the patient.

Approximately 10,000 postmenopausal women suffering from hormone receptor-positive breast cancer were followed by researchers in the Netherlands to study the effect of age on incidence and fatality due to the disease. Approximately 1,350 women in the group were over 75 years of age and 3,000 women between 65 and 74 years of age. They is discovered women in the 65-74 age group had 25% higher risk of succumbing to breast cancer when compared to women below the age of 65 years. The risk increased to 63% in women over 75 years.

Approximately 5 in 100 cases younger than 65 years died from breast cancer within five years of acquiring the disease, while the rate increased to 6 in 100 cases for women between 65 to 74 years of age. Findings from the study directly showed non-metastatic breast cancer patients beyond menopausal age had higher risk of dying, and the risk increased proportionately with age.

The Journal of the American Medical Association published findings on the study in its Feb. 8, 2012 issue. It has generated interest among American scientists, as further research could help study background information with the hope of reducing number of deaths due to breast cancer. Our Canadian pharmacy reminds readers approximately 226,000 new cases of breast cancer are detected in USA every year. A direct link has now been discovered related to age.

Demographics play an important role in establishing survival rate in patients. Age-related death due to breast cancer can be effectively reduced by increasing characteristics that make up the population. For example, various factors including age and location make considerable difference in increasing life expectancy, especially among older women suffering from hormone receptor-positive breast cancer.

Another important factor recorded by researchers was that older women had larger tumors as compared to younger women. It dramatically increased the risk of death. Though age also reduces intensity of cancerous growth, several other factors were responsible for increased fatality rate.

For instance, older women demonstrated lower immunity and would probably have less capacity to withstand chemotherapy when compared to younger patients. Dependence on medication will be another factor increasing the risk. People buy Arimidex, as the drug is known to slow down tumor growth, thereby offering more options for treating patients unable to withstand strenuous invasive procedures including chemotherapy and surgery.

Several factors have to be considered, according to our generic Canadian pharmacy. It may be possible older women respond differently to medication. Less tolerance to chemotherapy and invasive procedures may force researchers to find better techniques to specifically handle older patients. Screenings must be conducted more frequently as patients grow older. It will help oncologists keep track of tumor size to initiate a more effective medical regimen.